Status:
Topic prioritisation
Technology type:
Medicine
Decision:
Not selected
Reason for decision:
Not eligible for Health Technology Evaluation guidance
Rationale:
This product was discussed at the Topic Selection Oversight Panel (TSOP), with membership from NICE, Department of Health and Social Care (DHSC) and NHS England and Improvement, in June 2022 to carefully consider the suitability of this topic for potential guidance development. The panel noted that due to existing commissioning arrangement in place for Targeted Therapies for use in Pulmonary Hypertension in Adults, a NICE TA would not add value and the panel subsequently agreed to not progress further.
ID number:
10517

Project Team

Project lead
danielle.lees@nice.org.uk

Email enquiries

If you have any queries please email Topic.Selection@nice.org.uk


For further information on how we select topics for development, please see our page about topic prioritisation